- Patent Title: Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
-
Application No.: US14990582Application Date: 2016-01-07
-
Publication No.: US10716760B2Publication Date: 2020-07-21
- Inventor: Sami Karaborni , Sarina Grace Harris Ma , Chen Mao , Ching Wah Chong , Peter Robert Prinz Freed , Mesut Ciper , Stefanie Krenzlin , David J. Wustrow , Peter A. Virsik
- Applicant: XENOPORT, INC.
- Applicant Address: US GA Atlanta
- Assignee: Arbor Pharmaceuticals, LLC
- Current Assignee: Arbor Pharmaceuticals, LLC
- Current Assignee Address: US GA Atlanta
- Agency: King & Spalding
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K9/16 ; A61K9/20 ; A61K31/225 ; A61K31/215 ; A61K31/27 ; A61K31/5375 ; A61K9/14 ; A61K9/48
Abstract:
Improved oral dosage forms of methyl hydrogen fumarate and prodrugs thereof are disclosed. Methods of treating diseases such as multiple sclerosis and psoriasis using such dosage forms are also disclose.
Public/Granted literature
- US20170157056A9 ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF Public/Granted day:2017-06-08
Information query
